Oxford, MS, United States of America

Sandeep Misra


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sandeep Misra: Innovator in Radical Dosimetry

Introduction

Sandeep Misra is a notable inventor based in Oxford, MS (US). He has made significant contributions to the field of biopharmaceuticals and biological molecules through his innovative research and patents. His work focuses on enhancing the analysis of these complex molecules, which is crucial for advancements in medical science.

Latest Patents

Sandeep Misra holds a patent for "Radical dosimetry for analysis of biopharmaceuticals and biological molecules." This patent involves a method for performing three-dimensional structural analysis of pharmaceutical and biological molecules by utilizing the reaction of OH radicals on their surfaces. The quantitation and completeness of the OH radicals are measured using buffers intrinsic to the sample solutions as internal standards. This approach allows for accurate measurements while avoiding the unwanted effects that prior art internal standards may have on the three-dimensional structures of interest.

Career Highlights

Sandeep Misra is associated with Gennext Technologies, Inc., where he applies his expertise in radical dosimetry. His innovative methods have the potential to revolutionize the way biopharmaceuticals are analyzed, leading to improved drug development processes. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Sandeep has collaborated with notable colleagues, including Scot Randy Weinberger and Joshua Shane Sharp. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in biopharmaceutical analysis.

Conclusion

Sandeep Misra's contributions to the field of radical dosimetry exemplify the importance of innovation in biopharmaceutical research. His patent and work at Gennext Technologies, Inc. highlight his commitment to advancing scientific understanding and improving analytical methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…